Skip to content

Gait Assessment Via Telephone Application

Validity and Reliability of a Smartphone Application for Gait Assessment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06157749
Enrollment
34
Registered
2023-12-06
Start date
2024-07-31
Completion date
2025-09-30
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health, Subjective

Keywords

3D Computerized Gait Analysis, Gait-Analyzer, Gait Analysis, Smartphone Application

Brief summary

The evaluation of human gait is a crucial component of the clinical assessment and decision-making process. The gold standard in gait analysis is computerized gait analysis, which allows for three-dimensional digital data acquisition through computers (3D Computerized Gait Analysis). However, this technology is not readily accessible in routine analyses, as it proves to be a time-consuming and expensive endeavor in terms of infrastructure and human resources. The utilization of smartphones in clinical applications is on the rise, facilitated by the increasing accessibility of low-cost or free applications, thereby addressing the limitations associated with traditional gait analysis methods. The Gait-Analyzer application is among the mentioned applications. However, in the literature, no evidence has been found regarding the validity and reliability of Gait-Analyzer application compared to the gold standard 3D computerized gait analysis systems within the context of gait analyses. The aim of this study is to comparatively examine the effectiveness of the Gait-Analyzer smartphone application with established 3D Computerized Gait Analysis systems, which have proven validity and reliability in gait analyses. Through this research, the study intends to elucidate the validity and reliability of spatiotemporal parameters of walking within the Gait-Analyzer smartphone application.

Detailed description

Voluntary healthy participants will be included in the study. Signed voluntary consent will be obtained from participants. Participants will be divided into two groups. 3D Computerized Gait Analysis will be applied to one group first, and Gait-Analyzer smarthphone application will be applied to the other group first.

Interventions

OTHERGait analysis

It will be carried out on a 10-meter flat surface, with the participant walking at normal walking speed.

Sponsors

Istanbul University - Cerrahpasa
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 26 Years

Inclusion criteria

* Age between 18 and 26 years. * Body Mass Index (BMI) within normal limits (18.5-24.9 kg/m2)

Exclusion criteria

* Presence of lower extremity rotational problems (such as high femoral anteversion, internal tibial torsion, metatarsus adductus). * History of Botulinum Toxin Type A (BoNT-A) application or surgery within the last 6 months. * History of lower extremity injury within the last 6 months. * Leg length discrepancy. * Presence of third-degree pes planus. * Any neurological, rheumatic, musculoskeletal, metabolic, or connective tissue diseases. * History of pain, deformity, or surgery related to the vertebral column and upper extremities. * Presence of cognitive, mental, and/or severe psychiatric disorders

Design outcomes

Primary

MeasureTime frameDescription
Three-Dimensional Computerized Gait Analysischange from baseline at first weekReflective markers are placed on specific anatomical points to record varying joint angles throughout the walking cycle. Patients walk a distance of 9-10 meters, capturing records of their walking patterns and speed in everyday life, either barefoot or using assistive walking devices.
Gait-Analyzerchange from baseline at first weekGait-Analyzer is a mobile application for smartphones capable of real-time analysis of walking parameters. Using a smartphone with an Android processor and the Gait Analyzer application, directly attached to the participants' lumbar spine (nearest to L5) with a waist belt, participants will be instructed to complete 6 laps (12 forward and backward walks) on a 10-meter walking path.

Countries

Turkey (Türkiye)

Contacts

Primary ContactAyşenur Erekdağ, MSc
aysenurerekdag@gmail.com05548959013

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026